BI-9564
CAS No. 1883429-22-8
BI-9564 ( BI 9564;BI9564 )
Catalog No. M12927 CAS No. 1883429-22-8
BI-9564 (BI9564) is a potent, selective, cell-permeable and noncytotoxic BRD9 bromodomain inhibitor with IC50 of 75 nM, Kd of <20 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
|
10MG | 80 | In Stock |
|
25MG | 169 | In Stock |
|
50MG | 322 | In Stock |
|
100MG | 473 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBI-9564
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI-9564 (BI9564) is a potent, selective, cell-permeable and noncytotoxic BRD9 bromodomain inhibitor with IC50 of 75 nM, Kd of <20 nM.
-
DescriptionBI-9564 (BI9564) is a potent, selective, cell-permeable and noncytotoxic BRD9 bromodomain inhibitor with IC50 of 75 nM, Kd of <20 nM; displays 45-fold selectiveity over BRD7, and >5,000-fold over BRD4-BD1, BRD4-BD2, and BRD2-BD1; blocks EOL-1 cell proliferation with EC50 of 0.8 uM, and displays antitumor activity in an AML xenograft model.
-
SynonymsBI 9564;BI9564
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBRD7;BRD9;CECR2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1883429-22-8
-
Formula Weight353.41
-
Molecular FormulaC20H23N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 7.2 mg/mL (Need warming)
-
SMILESO=C1N(C)C=C(C2=CC(OC)=C(CN(C)C)C=C2OC)C3=CC=NC=C13
-
Chemical Name4-(4-((dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martin LJ, et al. J Med Chem. 2016 May 26;59(10):4462-75.
2. Krmer KF, et al. Int J Mol Sci. 2017 Jul 16;18(7). pii: E1537.
2. Krmer KF, et al. Int J Mol Sci. 2017 Jul 16;18(7). pii: E1537.
molnova catalog
related products
-
MS645
MS645 (MS-645) is a novel, bivalent bromodomain (BRD) inhibitor with Ki of 18.4 nM for tandem BD1-BD2 (BRD4 BD1/BD2 ).
-
CPI203
CPI 203 (TEN 010, JQ-2, RG-6146) is a primary amide analog of (+)-JQ1and a BET bromodomain inhibitor that shows cytotoxicity against MCL cell lines with GI50 of 0.1-0.3 uM.
-
MS-417
MS-417 (GTPL-7512) is a highly specific BET bromodomain inhibitor that binds to BRD4-BD1 and BRD4 BD2 with Kd of 36.1 uM and 25.4 uM respectively.